Matt Holt

It's great to see you again, Prashant.

It's nice to catch up after five years.

I would say this.

We've been studying and investing in the healthcare technology market for approximately 15 years.

Over the first 10 years, there were really three core tenets that determined our framework behind which we're investing capital.

The first one has been the reduction of administration costs and the reduction of administration inefficiency.

converting paper to digital, converting manual to automation process.

That's always been tenant number one.

Tenant number two, historically, has been enablement of the shift towards an outcomes-based system.

And number three has been, if you're successful in number one, in supporting digitization along the way you generate data and information.

So I'd say historically, those have been the three core tenets that have driven our investment framework and strategy.

Over the past five years, those three tenants have really expanded into six.

It's really based on the market becoming larger, more nuanced, and we believe there are new market drivers that we're now adding to our core tenants.

So those six tenants going forward include the empowerment of patients,

We're finally entering the moment of time in the industry where consumers have a stake, patients have a stake, they have a voice.

Number two, the democratization of patient data and information.

Number three, the acceleration of interoperability, breaking the silos between data and information sources.

Number four, the removal of waste and the restoration of trust.

Number five, the convergence of clinical and financial decision-making.

And number six, the enablement of next-generation research.